BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP
- Author
- LINGFORD-HUGHES, A. R1 ; WELCH, S2 ; DUKA, T; FINCH, E; LAW, F; MARSHALL, E. J; MUNAFO, M; MYLES, J; PORTER, S; RAISTRICK, D; REED, L. J; REID, A; PETERS, L3 ; SELL, L; SINCLAIR, J; TYRER, P; WEST, R; WILLIAMS, T; WINSTOCK, A; NUTT, D. J1 ; BUNTWAL, N; CHICK, J; CROME, I; DALY, C; DAR, K; DAY, E
[1] Imperial College London, CNWL NHS Foundation Trust, London, United Kingdom
[2] Gether NHS Foundation Trust, Gloucester, United Kingdom
[3] Pennine Care NHS Foundation Trust, Ashton-under-Lyne, United Kingdom - Source
Journal of psychopharmacology (Oxford). 2012, Vol 26, Num 7, pp 899-952, 54 p ; ref : 13 p.3/4
- ISSN
- 0269-8811
- Scientific domain
- Cognition; Pharmacology drugs; Psychology, psychopathology, psychiatry
- Publisher
- Sage Publications, London
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- Substance misuse addiction comorbidity guidelines pharmacotherapy
- Keyword (fr)
- Abus de substance Addiction Association morbide Benzo[a]pyrène Conduite à tenir Pharmacothérapie Pratique basée sur des preuves Recommandation Substance toxicomanogène Traitement
- Keyword (en)
- Substance abuse Addiction Concomitant disease Clinical management Pharmacotherapy Evidence-based practice Recommendation Drug of abuse Treatment
- Keyword (es)
- Abuso de sustancias Adicción Asociación morbosa Actitud médica Farmacoterapia Práctica basada en la evidencia Recomendación Sustancia toxicomanógena Tratamiento
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 26107897
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1177/0269881112444324 
https://dx.doi.org/10.1177/0269881112444324
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1177\/0269881112444324\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:169:\"BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of psychopharmacology (Oxford)\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. psychopharmacol. (Oxf.)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"899\";s:8:\"\u0000*\u0000epage\";s:3:\"952\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-8811\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:15:\"LINGFORD-HUGHES\";s:10:\"\u0000*\u0000aufirst\";s:4:\"A. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:25:{i:0;s:8:\"WELCH, S\";i:1;s:7:\"DUKA, T\";i:2;s:8:\"FINCH, E\";i:3;s:6:\"LAW, F\";i:4;s:14:\"MARSHALL, E. J\";i:5;s:9:\"MUNAFO, M\";i:6;s:8:\"MYLES, J\";i:7;s:9:\"PORTER, S\";i:8;s:12:\"RAISTRICK, D\";i:9;s:10:\"REED, L. J\";i:10;s:7:\"REID, A\";i:11;s:9:\"PETERS, L\";i:12;s:7:\"SELL, L\";i:13;s:11:\"SINCLAIR, J\";i:14;s:8:\"TYRER, P\";i:15;s:7:\"WEST, R\";i:16;s:11:\"WILLIAMS, T\";i:17;s:11:\"WINSTOCK, A\";i:18;s:10:\"NUTT, D. J\";i:19;s:10:\"BUNTWAL, N\";i:20;s:8:\"CHICK, J\";i:21;s:8:\"CROME, I\";i:22;s:7:\"DALY, C\";i:23;s:6:\"DAR, K\";i:24;s:6:\"DAY, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:169:\"BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Sage Publications\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"54\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1177\/0269881112444324\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:169:\"BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of psychopharmacology (Oxford)\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. psychopharmacol. (Oxf.)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"899\";s:8:\"\u0000*\u0000epage\";s:3:\"952\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-8811\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:15:\"LINGFORD-HUGHES\";s:10:\"\u0000*\u0000aufirst\";s:4:\"A. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:25:{i:0;s:8:\"WELCH, S\";i:1;s:7:\"DUKA, T\";i:2;s:8:\"FINCH, E\";i:3;s:6:\"LAW, F\";i:4;s:14:\"MARSHALL, E. J\";i:5;s:9:\"MUNAFO, M\";i:6;s:8:\"MYLES, J\";i:7;s:9:\"PORTER, S\";i:8;s:12:\"RAISTRICK, D\";i:9;s:10:\"REED, L. J\";i:10;s:7:\"REID, A\";i:11;s:9:\"PETERS, L\";i:12;s:7:\"SELL, L\";i:13;s:11:\"SINCLAIR, J\";i:14;s:8:\"TYRER, P\";i:15;s:7:\"WEST, R\";i:16;s:11:\"WILLIAMS, T\";i:17;s:11:\"WINSTOCK, A\";i:18;s:10:\"NUTT, D. J\";i:19;s:10:\"BUNTWAL, N\";i:20;s:8:\"CHICK, J\";i:21;s:8:\"CROME, I\";i:22;s:7:\"DALY, C\";i:23;s:6:\"DAR, K\";i:24;s:6:\"DAY, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:169:\"BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Sage Publications\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"54\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:24:\"10.1177\/0269881112444324\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1177\/0269881112444324\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:169:\"BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of psychopharmacology (Oxford)\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. psychopharmacol. (Oxf.)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"899\";s:8:\"\u0000*\u0000epage\";s:3:\"952\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-8811\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:15:\"LINGFORD-HUGHES\";s:10:\"\u0000*\u0000aufirst\";s:4:\"A. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:25:{i:0;s:8:\"WELCH, S\";i:1;s:7:\"DUKA, T\";i:2;s:8:\"FINCH, E\";i:3;s:6:\"LAW, F\";i:4;s:14:\"MARSHALL, E. J\";i:5;s:9:\"MUNAFO, M\";i:6;s:8:\"MYLES, J\";i:7;s:9:\"PORTER, S\";i:8;s:12:\"RAISTRICK, D\";i:9;s:10:\"REED, L. J\";i:10;s:7:\"REID, A\";i:11;s:9:\"PETERS, L\";i:12;s:7:\"SELL, L\";i:13;s:11:\"SINCLAIR, J\";i:14;s:8:\"TYRER, P\";i:15;s:7:\"WEST, R\";i:16;s:11:\"WILLIAMS, T\";i:17;s:11:\"WINSTOCK, A\";i:18;s:10:\"NUTT, D. J\";i:19;s:10:\"BUNTWAL, N\";i:20;s:8:\"CHICK, J\";i:21;s:8:\"CROME, I\";i:22;s:7:\"DALY, C\";i:23;s:6:\"DAR, K\";i:24;s:6:\"DAY, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:169:\"BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Sage Publications\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"54\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1177\/0269881112444324\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:169:\"BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of psychopharmacology (Oxford)\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. psychopharmacol. (Oxf.)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"899\";s:8:\"\u0000*\u0000epage\";s:3:\"952\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-8811\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:15:\"LINGFORD-HUGHES\";s:10:\"\u0000*\u0000aufirst\";s:4:\"A. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:25:{i:0;s:8:\"WELCH, S\";i:1;s:7:\"DUKA, T\";i:2;s:8:\"FINCH, E\";i:3;s:6:\"LAW, F\";i:4;s:14:\"MARSHALL, E. J\";i:5;s:9:\"MUNAFO, M\";i:6;s:8:\"MYLES, J\";i:7;s:9:\"PORTER, S\";i:8;s:12:\"RAISTRICK, D\";i:9;s:10:\"REED, L. J\";i:10;s:7:\"REID, A\";i:11;s:9:\"PETERS, L\";i:12;s:7:\"SELL, L\";i:13;s:11:\"SINCLAIR, J\";i:14;s:8:\"TYRER, P\";i:15;s:7:\"WEST, R\";i:16;s:11:\"WILLIAMS, T\";i:17;s:11:\"WINSTOCK, A\";i:18;s:10:\"NUTT, D. J\";i:19;s:10:\"BUNTWAL, N\";i:20;s:8:\"CHICK, J\";i:21;s:8:\"CROME, I\";i:22;s:7:\"DALY, C\";i:23;s:6:\"DAR, K\";i:24;s:6:\"DAY, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:169:\"BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Sage Publications\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"54\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1177\/0269881112444324\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:169:\"BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of psychopharmacology (Oxford)\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. psychopharmacol. (Oxf.)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"899\";s:8:\"\u0000*\u0000epage\";s:3:\"952\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-8811\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:15:\"LINGFORD-HUGHES\";s:10:\"\u0000*\u0000aufirst\";s:4:\"A. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:25:{i:0;s:8:\"WELCH, S\";i:1;s:7:\"DUKA, T\";i:2;s:8:\"FINCH, E\";i:3;s:6:\"LAW, F\";i:4;s:14:\"MARSHALL, E. J\";i:5;s:9:\"MUNAFO, M\";i:6;s:8:\"MYLES, J\";i:7;s:9:\"PORTER, S\";i:8;s:12:\"RAISTRICK, D\";i:9;s:10:\"REED, L. J\";i:10;s:7:\"REID, A\";i:11;s:9:\"PETERS, L\";i:12;s:7:\"SELL, L\";i:13;s:11:\"SINCLAIR, J\";i:14;s:8:\"TYRER, P\";i:15;s:7:\"WEST, R\";i:16;s:11:\"WILLIAMS, T\";i:17;s:11:\"WINSTOCK, A\";i:18;s:10:\"NUTT, D. J\";i:19;s:10:\"BUNTWAL, N\";i:20;s:8:\"CHICK, J\";i:21;s:8:\"CROME, I\";i:22;s:7:\"DALY, C\";i:23;s:6:\"DAR, K\";i:24;s:6:\"DAY, E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:169:\"BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Sage Publications\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"54\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
